Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Androgenetic alopecia is more common in Saudi men than women.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

New alopecia treatments aim for better results and fewer side effects.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Hair loss may increase heart disease risk.

Hair loss lotion with specific ingredients effectively improves hair growth and thickness safely.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Early hair loss may indicate prostate issues.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.